AbbVie has finally claimed FDA approval for its advanced Parkinson's disease therapy Vyalev, 18 months after the US regulator turned it down with a request for more data. Now, Vyalev (foscarbidopa and ...
Commercial vessels are deploying high-tech sensors to map a shifting sea, providing critical data for scientists and some help for the industry. By Eric Niiler and Tristan Spinski The panel voted to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results